tiprankstipranks

Matthew T. Wiley Insider Profile

11 Followers
Matthew T. Wiley, CCO at Definium Therapeutics, holds 237.13K shares in Definium Therapeutics (Ticker: DFTX), holds 19.01K shares in Bioxcel Therapeutics (Ticker: BTAI), holds 109.25K shares in Yarrow Bioscience (Ticker: YARW).
tipranks
Matthew T. Wiley

Matthew T. Wiley
Definium Therapeutics (DFTX)
CCO

Not Ranked
Matthew T. Wiley has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$13M
73.79%
26.20%
0.02%
A breakdown of Matthew T. Wiley's holdings

Insider Roles

Definium Therapeutics
(DFTX)
CCO
Yarrow Bioscience
(YARW)
CCO
Bioxcel Therapeutics
(BTAI)
See Remarks
Roles that Matthew T. Wiley holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Matthew T. Wiley

Matthew T. Wiley's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Definium Therapeutics
Aug 12, 2026
CCO
Uninformative Buy
$9.22M
FOMX
Foamix Pharma
Feb 24, 2020
Uninformative Buy
$335.12K
Yarrow Bioscience
Jul 02, 2021
CCO
Uninformative Sell
18.08K
$3.28M
Bioxcel Therapeutics
Oct 03, 2024
See Remarks
Uninformative Buy
$2.03K
List of latest transactions for each holding click on a transaction to see Matthew T. Wiley's performance on stock

Matthew T. Wiley insider profile FAQ

What is the percentage of profitable transactions made by Matthew T. Wiley?
The percentage of profitable transactions made by Matthew T. Wiley is ―.
    What is the average return per transaction made by Matthew T. Wiley?
    The average return per transaction made by Matthew T. Wiley is ―.
      What stocks does Matthew T. Wiley hold?
      Matthew T. Wiley holds: DFTX, FOMX, YARW, BTAI stocks.
        What was Matthew T. Wiley’s latest transaction?
        Matthew T. Wiley latest transaction was an Uninformative Buy of ―.
          What was Matthew T. Wiley's most profitable transaction?
          Matthew T. Wiley’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Matthew T. Wiley's role in Definium Therapeutics?
            Matthew T. Wiley's role in Definium Therapeutics is CCO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.